Open access · CC-BY
via OpenAlex
Nicotinamide riboside supplementation protects against maternal diabetes-associated decline in oocyte quality
Chenlu Wei, Xinxin Zeng, Keer Wang, Mengchen Wang, Min Lei, Zhenye Zhu, Yining Xu, Yanqing Zhao, Qingling Yang, Yingpu Sun
Reproduction · 2025 · ▲ 2 citations
Abstract
In brief: NAD+ levels were reduced in streptozotocin (STZ)-induced diabetic mice, but nicotinamide riboside (NR) supplementation improved these levels in diabetic ovaries and oocytes, enhancing oocyte quality and early embryo development by improving mitochondrial function and lowering reactive oxygen species (ROS) levels. Abstract: Diabetes mellitus is strongly correlated with a decline in oocyte quality; however, noninvasive and effective methods to improve this issue have yet to be fully development. Here, we demonstrate that in vivo supplementation with NR 400 mg/kg/day for 14 days effectively enhances the quality of oocytes from diabetic mice induced by streptozocin 190 mg/kg by restoring nicotinamide adenine dinucleotide (NAD+) levels. NR supplementation not only improved superovulation function of diabetic mice but also improved their oocyte quality and embryonic development potential after fertilization by maintaining normal spindle structure and alleviating mitochondrial dysfunction(definition). In addition, NR supplementation reduced ROS levels in oocytes from diabetic mice. Overall, our findings suggest that dietary NR supplementation is a viable strategy to protect oocytes from diabetes-related deterioration, thereby enhancing reproductive outcomes in maternal diabetes and improving the efficacy of assisted reproductive technology.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1530/rep-24-0350
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Wei, C., Zeng, X., Wang, K., Wang, M., Lei, M., Zhu, Z., Xu, Y., Zhao, Y., Yang, Q., & Sun, Y. (2025). Nicotinamide riboside supplementation protects against maternal diabetes-associated decline in oocyte quality. <em>Reproduction</em>. https://doi.org/10.1530/rep-24-0350
Vancouver
Wei C, Zeng X, Wang K, Wang M, Lei M, Zhu Z, et al. Nicotinamide riboside supplementation protects against maternal diabetes-associated decline in oocyte quality. Reproduction. 2025. doi:10.1530/rep-24-0350.
BibTeX
@article{chenlu2025Nicoti,
title = {Nicotinamide riboside supplementation protects against maternal diabetes-associated decline in oocyte quality},
author = {Chenlu Wei and Xinxin Zeng and Keer Wang and Mengchen Wang and Min Lei and Zhenye Zhu and Yining Xu and Yanqing Zhao and Qingling Yang and Yingpu Sun},
journal = {Reproduction},
year = {2025},
doi = {10.1530/rep-24-0350},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Ovarian Research 2025
Open access · CC-BY
Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model
iScience 2021
Open access · CC-BY
Nicotinamide riboside supplementation confers marginal metabolic benefits in obese mice without remodeling the muscle acetyl-proteome
Journal of the American Society of Hypertension 2016
Citation only
Nicotinamide nucleotide transhydrogenase activity impacts mitochondrial redox balance and the development of hypertension in mice
Aging Cell 2023
Open access · CC-BY
Deletion of enzymes for de novo NAD + biosynthesis accelerated ovarian aging
Journal of Assisted Reproduction and Genetics 2024
Open access · CC-BY
The NAD+ precursor nicotinamide riboside protects against postovulatory aging in vitro
Frontiers in Cell and Developmental Biology 2022
Open access · CC-BY